1. Home
  2. CVV vs RNAZ Comparison

CVV vs RNAZ Comparison

Compare CVV & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVD Equipment Corporation

CVV

CVD Equipment Corporation

HOLD

Current Price

$4.28

Market Cap

32.5M

Sector

Technology

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$1.76

Market Cap

27.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVV
RNAZ
Founded
1982
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.5M
27.9M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
CVV
RNAZ
Price
$4.28
$1.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 110.3K
45.4K
Earning Date
11-09-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 17.86
N/A
EPS
★ 1.58
N/A
Revenue
★ $41,128,639.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.77
★ N/A
Revenue Growth
★ 96.27
N/A
52 Week Low
$2.96
$1.52
52 Week High
$9.10
$20.99

Technical Indicators

Market Signals
Indicator
CVV
RNAZ
Relative Strength Index (RSI) 28.03 39.34
Support Level $3.79 $1.58
Resistance Level $4.90 $2.39
Average True Range (ATR) 0.20 0.22
MACD 0.04 0.11
Stochastic Oscillator 36.62 28.74

Price Performance

Historical Comparison
CVV
RNAZ

About CVV CVD Equipment Corporation

CVD Equipment Corp designs, develops, and manufactures a broad range of equipment used to develop and produce materials and coatings for the aerospace, compound semiconductor, semiconductor, aerospace, battery energy storage markets as well as industrial applications, and research. It currently conducts its business through two reportable segments: CVD Equipment, which designs and manufactures chemical vapor deposition, physical vapor transport and thermal process equipment; and SDC, which designs and manufactures ultra-high purity gas and chemical delivery control systems. Its target markets are aerospace & defense and industrial, microelectronics / high power electronics, and EV battery materials / energy storage.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: